Simtuzumab
N/A
Report date: 2026/05/20 20:02:01
Base Information
Drug NameSimtuzumab
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[10]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[19]
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGilead Sciences Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesGilead Sciences Inc
Active IndicationsN/A
Inactive Indications +[10]
Other Information
ATC CodeN/A
Related LinksWikipedia